Visudyne

by Novartis/Nouveaux

Active ingredient: Verteporfin

Packs

• Inj · Vial (031367)

About Verteporfin

Other Ophthalmologicals

Uses

Age-related macular degeneration with predominantly classic subfoveal choroidal neovascularisation or occult subfoveal choroidal neovascularisation with ongoing disease progression. Subfoveal choroidal neovascularisation secondary to pathological myopia. See literature.

How to take it

See literature. Administration should be done under the supervision of expert medical practitioners only. IV: The full infusion volume is administered IV over 10 min at a rate of 3 mL/min, using an appropriate syringe pump and in-line filter. Following injection with verteporfin, care should be taken to avoid exposure of skin or eyes to direct sunlight or bright indoor light for 5 days. Stability: Store verteporfin between 20°C-25°C (68°-77°F).

Pregnancy and breastfeeding

Contraindications: See literature. Precautions: See literature.

Full information on Verteporfin →

Need Visudyne? Ask us to source Visudyne and our pharmacist will call you back.

More from Novartis/Nouveaux

• Ultibro breezhaler
• Uperio
• Vigamox
• Viskaldix
• Voltral
• Votrient
• Xolair
• Zometa

Compiled by Healify Pharmacy from published drug references. How we compile it →

Always consult a pharmacist or doctor.